PROK

Prokidney Stock Analysis

AI Rating

Neutral
  • Quality5/10
  • Growth↓ 3/10
  • Momentum↑ 8/10
Prokidney sales and earnings growth
PROK Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ 0.00%
  • FCF Y/Y↓ -10.21%
Prokidney gross and profit margin trends
PROK Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -9547.40%
  • ROIC↓ -24.90%
Prokidney net debt vs free cash flow
PROK Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -13465.4

Prokidney stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗